Dangerous Liaisons between Beta-Amyloid and Cholinergic Neurotransmission
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
2525-2538
Author(s):
Stefano Govoni, Elisa Mura, Stefania Preda, Marco Racchi, Cristina Lanni, Massimo Grilli, Stefania Zappettini, Alessia Salamone, Guendalina Olivero, Anna Pittaluga and Mario Marchi
Getting Rid of Intracellular Aβ - Loss of Cellular Degradation Leads to Transfer Between Connected Neurons
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
2458-2468
Author(s):
Lotta Agholme and Martin Hallbeck
Is Fibroblast Growth Factor Receptor 4 a Suitable Target of Cancer Therapy?
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
2881-2898
Author(s):
Christine Heinzle, Zeynep Erdem, Jakob Paur, Bettina Grasl-Kraupp, Klaus Holzmann, Michael Grusch, Walter Berger and Brigitte Marian
Reprogrammed Metabolism of Cancer Cells as a Potential Therapeutic Target
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
2580-2594
Author(s):
Jaap Keijer and Dorien A.M. van Dartel
Glutamine, Glucose and other Fuels for Cancer
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
2557-2579
Author(s):
Maria Victoria Ruiz-Perez, Francisca Sanchez-Jimenez, Francisco J. Alonso, Juan A. Segura, Javier Marquez and Miguel Angel Medina
Advances in Targeting Insulin-like Growth Factor Signaling Pathway in Cancer Treatment
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
2899-2911
Author(s):
Liangkun You, Changyu Liu, Hexiao Tang, Yongde Liao and Shengling Fu
Regulation of MET Receptor Signaling by SOCS1 and its Implications for Hepatocellular Carcinoma
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
2922-2933
Author(s):
Yirui Gui, Mehdi Yeganeh, Yuneivy Cepero-Donates, Sheela Ramanathan, Caroline Saucier and Subburaj Ilangumaran
Radiolabeled Probes Targeting Tyrosine-Kinase Receptors For Personalized Medicine
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
2275-2292
Author(s):
Mohamed Altai, Anna Orlova and Vladimir Tolmachev
Reduction in Ischemic Cerebral Infarction is Mediated through Golgi Phosphoprotein 3 and Akt/mTOR Signaling Following Salvianolate Administration
Journal:
Current Neurovascular Research
Volume:
11
Page:
107-113
Author(s):
Hong You, Ting Li, Jinnan Zhang, Qiang Lei, Xi Tao, Pinghui Xie and Wei Lu
Mesenchymal Stromal Cell Therapy for Cardio Renal Disorders
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
2412-2429
Author(s):
Marlies E.J. Reinders, Danielle G. Leuning, Johan W. de Fijter, Martin.J. Hoogduijn and Ton J. Rabelink